NKTR-218

N/A

Report date: 2021/12/10 18:15:13
NME

Base Information

Drug NameNKTR-218
Drug Alias NameNKTR-218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNektar Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNektar Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A